← FDA DRUG APPROVALS

FDA ANDA · ANDA075780

FLUTAMIDE

Sponsor: CIPLA

APPLICATION
ANDA075780
TYPE
ANDA
ORIGINAL APPROVAL
2001-09-19
LATEST ACTION
2007-10-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FLUTAMIDEDiscontinued
FLUTAMIDE 125MG · CAPSULE · ORAL

Approval history

2007-10-01Labeling · Supplement 3AP
2001-09-19OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →